Do religious/spiritual coping strategies affect illness adjustment in patients with cancer? A systematic review of the literature

2006 ◽  
Vol 63 (1) ◽  
pp. 151-164 ◽  
Author(s):  
Ingela C. Thuné-Boyle ◽  
Jan A. Stygall ◽  
Mohammed R. Keshtgar ◽  
Stanton P. Newman
Author(s):  
Rebecca C. Grossman

The imposter phenomenon, or imposter syndrome, is defined as an internal experience of feeling like an intellectual fraud, despite external evidence of an individual's accomplishments, and results in an inability to internalise a sense of success. It is common among high-achieving people, and appears to be more common in women and ethnic minorities. In this chapter, a systematic review of the literature will be presented on imposter syndrome in the medical profession. Topics covered include purported aetiology, implications (including the impact on mental health and career progression), limitations of research, potential coping strategies, and avenues for future research.


2013 ◽  
Vol 69 (3) ◽  
pp. e121-e128 ◽  
Author(s):  
Kira Minkis ◽  
Benjamin C. Garden ◽  
Shenhong Wu ◽  
Melissa P. Pulitzer ◽  
Mario E. Lacouture

2015 ◽  
Vol 14 (1) ◽  
pp. 77-84 ◽  
Author(s):  
Fernando Espi Forcen ◽  
Konstantina Matsoukas ◽  
Yesne Alici

AbstractObjective:Akathisia is a neuropsychiatric syndrome characterized by subjective and objective restlessness. It is a common side effect in patients taking antipsychotics and other psychotropics. Patients with delirium are frequently treated with antipsychotic medications that are well known to induce akathisia as a side effect. However, the prevalence, phenomenology, and management of akathisia in patients with delirium remain largely unknown. The purpose of this review was to examine the medical literature in order to establish the current state of knowledge regarding the prevalence of antipsychotic-induced akathisia in patients with delirium.Method:A systematic review of the literature was conducted using the EMBASE, MEDLINE, PsycINFO, and CINAHL databases. Ten studies addressing the incidence of akathisia in patients taking antipsychotic medication for delirium were identified and included in our review.Results:The included studies reported a variable prevalence of antipsychotic-induced akathisia. A higher prevalence was found in patients taking haloperidol. Among atypical antipsychotics, paliperidone and ziprasidone were associated with a higher risk of akathisia. The risk for akathisia appeared to be a dose-related phenomenon.Significance of results:Studies using specific scales for evaluation of akathisia in delirium are lacking. Some populations, such as patients with cancer or terminally ill patients in palliative care settings taking antipsychotics for the treatment of delirium, could be at higher risk for development of akathisia as a side effect.


2007 ◽  
Vol 97 (5) ◽  
pp. 823-831 ◽  
Author(s):  
Ramón Colomer ◽  
José M. Moreno-Nogueira ◽  
Pedro P. García-Luna ◽  
Pilar García-Peris ◽  
Abelardo García-de-Lorenzo ◽  
...  

Use of n-3 fatty acids (FA) has been reported to be beneficial for cancer patients. We performed a systematic review of the literature in order to issue recommendations on the clinical use of n-3 FA in the cancer setting. A systematic search was performed in MEDLINE, EMBASE, Cochrane and Healthstar databases. We selected clinical trials or prospective observational studies including patients with cancer and life expectancy >2 months, in which enteral supplements with n-3 FA were administered. Parameters evaluated individually were clinical (nutritional status, tolerance, survival and hospital stays), biochemical (inflammatory mediators), and functional (functional status, appetite and quality of life (QoL)). Seventeen studies met the inclusion criteria; eight were of high quality. The panel of experts established the following evidence: (1) oral supplements with n-3 FA benefit patients with advanced cancer and weight loss, and are indicated in tumours of the upper digestive tract and pancreas; (2) the advantages observed were: increased weight and appetite, improved QoL, and reduced post-surgical morbidity; (3) there is no defined pattern for combining different n-3 FA, and it is recommended to administer >1·5 g/day; and (4) better tolerance is obtained administering low-fat formulas for a period of at least 8 weeks. All the evidences were grade B but for ‘length of treatment’ and ‘advantage of survival’ it was grade C. Our findings suggest that administration of n-3 FA (EPA and DHA) in doses of at least 1·5 g/day for a prolonged period of time to patients with advanced cancer is associated with an improvement in clinical, biological and QoL parameters.


2018 ◽  
Vol 9 (1) ◽  
pp. 6-14 ◽  
Author(s):  
Angéline Galvin ◽  
Fleur Delva ◽  
Catherine Helmer ◽  
Muriel Rainfray ◽  
Carine Bellera ◽  
...  

2015 ◽  
Vol 25 (4) ◽  
pp. 387-399 ◽  
Author(s):  
Stephanie E. Hullmann ◽  
Sheri L. Robb ◽  
Kevin L. Rand

2020 ◽  
Vol 5 (1) ◽  
pp. 326-338 ◽  
Author(s):  
Kristen Weidner ◽  
Joneen Lowman

Purpose We conducted a systematic review of the literature regarding adult telepractice services (screening, assessment, and treatment) from approximately 2014 to 2019. Method Thirty-one relevant studies were identified from a literature search, assessed for quality, and reported. Results Included studies illustrated feasibility, efficacy, diagnostic accuracy, and noninferiority of various speech-language pathology services across adult populations, including chronic aphasia, Parkinson's disease, dysphagia, and primary progressive aphasia. Technical aspects of the equipment and software used to deliver services were discussed. Some general themes were noted as areas for future research. Conclusion Overall, results of the review continue to support the use of telepractice as an appropriate service delivery model in speech-language pathology for adults. Strong research designs, including experimental control, across multiple well-described settings are still needed to definitively determine effectiveness of telepractice services.


Sign in / Sign up

Export Citation Format

Share Document